25.3 C
New York
Saturday, June 13, 2026

Tag: function

The Jackson Laboratory secures grant from The Michael J. Fox Foundation to advance Parkinson’s disease research through the JAX-NYSCF Collaborative

New human stem cell platform will expand access to standardized disease models, support Parkinson's disease research and therapeutic discovery efforts NEW YORK , June 9,...

Actuate Therapeutics’ Elraglusib Selected for Evaluation in BEACON2 Trial for High-Risk Pediatric Neuroblastoma

- BEACON2 is a landmark European multi-arm, multi-stage Phase 1/2 platform trial conducted and sponsored by the Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham 

- Elraglusib will be assessed in combination with dinutuximab beta plus chemotherapy in patients with relapsed and refractory neuroblastoma

- Complete response in neuroblastoma patient achieved in Phase 1 study of elraglusib in refractory pediatric cancers

Exilby® Receives First European Marketing Authorization as VERTANICAL Prepares UK Submission for its First-in-Class Non-Opioid Treatment for Chronic Low Back Pain

GRÄFELFING, Germany, June 9, 2026 /PRNewswire/ -- VERTANICAL today announced that Exilby® (VER-01) has received marketing authorization in Germany for the treatment of chronic...

万益特于ERA发布前沿临床数据:HDx 透析疗法是替代在线血液透析滤过的优选治疗方案

苏格兰格拉斯哥, June 09, 2026 (GLOBE NEWSWIRE) -- 万益特(Vantive),作为一家拥有70年肾脏护理创新历史的重要脏器疗法公司,今日发布两项突破性临床研究:采用 泰诺佳® 透析器的 HDx 疗法,与在线血液透析滤过(OL-HDF)相比,在全因死亡率和主要心血管结局方面*表现相似(统计学上非劣效)。1,2随机对照试验MOTheR 研究、真实世界研究CONCORDIA中期数据,已于 2026 年 6 月 3–6 日在苏格兰格拉斯哥举办的第 63届欧洲肾脏协会(ERA)大会上发布。

The Frederick Arts Council Announces Call For Artists For Ballenger Creek Trail Sculpture Pedestals

FREDERICK, Md., June 8, 2026 /PRNewswire/ -- The Frederick Arts Council (FAC) invites artists to submit proposals for two sculptural pedestals for permanent installation...

Ascendis to Showcase Advances in Treatment of Rare Endocrine Diseases at ENDO 2026

COPENHAGEN, Denmark, June 08, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest data from its Endocrinology Rare Disease programs in hypoparathyroidism, achondroplasia, and pediatric growth hormone deficiency will be shared in two oral presentations and three posters at ENDO 2026, the annual meeting of the Endocrine Society being held in Chicago from June 13-16, 2026.

AG1 LAUNCHES AG1 PRO WITH CREATINE AND MORE FOR ADVANCED MUSCLE AND GUT SUPPORT

AG1 Pro's advanced formula builds on AG1's clinically-backed formula to include additional research-backed key ingredients, including creatine, that target muscle strength, metabolic resilience, and...

Cabinetworks Group appoints Danielle Mikesell as new chief commercial officer

LIVONIA, Mich., June 8, 2026 /PRNewswire/ -- Cabinetworks Group, the country's largest privately owned cabinet manufacturer, recently announced it has appointed Danielle Mikesell as...

The CareBridge Group Pivots “Community Access Coalition” into Direct Grant Funding Engine; Invites Florida Nonprofits to Apply for $8.46 Million in Year 1 Capital

Bypassing municipal bureaucracy, the elite healthcare execution firm calls on operational nonprofits in Central Florida and Duval County to secure immediate, privately funded grants...

No Deposit Bonus Casinos for Real Money 2026: All iGaming Experts Reveal Casinos with Free Spins Bonuses

Vancouver, Canada, June 08, 2026 (GLOBE NEWSWIRE) --

 No deposit bonus casinos are receiving more attention in 2026 as players look for ways to try an online casino before spending their own money. Offers such as 50 no deposit free spins and $200 no deposit bonus 200 free spins real money allow users to test games, review bonus terms, and understand how a casino works before deciding whether to make a deposit.

National Kidney Foundation and U.S. Pharmacy Organizations Call for Transition to Race-Agnostic eGFR in Medication Decision-Making

NEW YORK, June 8, 2026 /PRNewswire/ -- A coalition of leading U.S. pharmacy organizations, in collaboration with the National Kidney Foundation (NKF), is urging...

Capricor Therapeutics to Present at Upcoming Investor Conferences

SAN DIEGO, June 08, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today announced that senior management will participate in the following upcoming investor conferences.  

Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution

StrataMap Spatial gives researchers access to spatial biology at true single cell resolution for discovery without boundariesWhole-transcriptome profiling across a large tissue capture area...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsFunction